The company
Achieve Life Sciences, Inc. - Common Shares
ACHV · Nasdaq
ACHV stood above a rising 150-day average in 45 of the last 52 weekly readings, including each of the last 25 weeks. It is 10.1% above that average now. Diagnostics & Labs: 52% of its 44 stocks in an uptrend (+5 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 25 in a row
- Industry in uptrend
- 52% +5 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $350K
- Officials’ trades on record
- 0
- Institutions holding
- 109 (+33)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 45 of 52 weeks.
Diagnostics & Labs: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Richard Alistair StewartDirector | sold | 20,626at $8.49 | 19 Aug 2026filed 21 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Frazier Life Sciences Management, L.P.new · filed 14 Aug 2026 | 7,614,836$49.7M | +7,614,836 |
| TPG GP A, LLCnew · filed 14 Aug 2026 | 6,877,580$44.9M | +6,877,580 |
| venBio Partners LLCnew · filed 14 Aug 2026 | 5,914,720$38.6M | +5,914,720 |
| Logos Global Management LPnew · filed 14 Aug 2026 | 5,425,000$35.4M | +5,425,000 |
| BlackRock, Inc.added · filed 7 Aug 2026 | 5,272,017$34.4M | +4,832,657+1099.9% |
| FRANKLIN RESOURCES INCadded · filed 13 Aug 2026 | 4,953,220$32.3M | +584,027+13.4% |
| Paradigm Biocapital Advisors LPnew · filed 14 Aug 2026 | 4,951,856$32.3M | +4,951,856 |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 4,140,812$27.0M | +1,936,098+87.8% |
| Propel Bio Management, LLCadded · filed 13 Aug 2026 | 4,034,018$26.3M | +247,593+6.5% |
| MARSHALL WACE, LLPadded · filed 13 Aug 2026 | 3,770,313$24.6M | +2,751,032+269.9% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.